Triclosan Antimicrobial Suture Segment to Lead Antimicrobial Surgical Suture Market During 2023–2031
According to our new research study on "Antimicrobial Surgical Suture Market Forecast to 2031 –Global Analysis – by Type, Raw Material, Application, End User, and Geography," the market size is expected to grow from US$ 0.35 billion in 2023 to US$ 0.75 billion by 2031; it is projected to register a CAGR of 9.9% during 2023–2031. The antimicrobial surgical suture market growth is attributed to the rising prevalence of surgical site infections, and increasing cases of chronic wounds and surgeries. Strategic initiatives by antimicrobial surgical suture manufacturers are likely to offer opportunities for market growth. However, noninvasive alternatives to stitches hinder the market growth.
Antimicrobial surgical sutures are coated or impregnated with chemicals harmful to microorganisms, which interfere with vital cell processes within bacterial cells. Antimicrobial coatings stop bacterial adhesion and growth on suture materials. The antimicrobial surgical suture market report emphasizes key factors impacting the market and showcases the developments of prominent players. Based on type, the antimicrobial surgical suture market is classified into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture segment held a larger antimicrobial surgical suture market share in 2023; it is estimated to register a higher CAGR during 2023–2031. The coating of triclosan, an antimicrobial agent, on surgical sutures helps reduce the risk of surgical site infections by inhibiting the growth of bacteria on the suture material. Triclosan antimicrobial sutures are used in various surgical procedures to provide the dual benefit of wound closure and infection prevention. This antimicrobial is effective against a broad range of bacteria, including Gram-positive and Gram-negative organisms. The antimicrobial coating is intended to prevent bacterial colonization on the suture material.
Antimicrobial Surgical Sutures Market, by Region, 2023 (%)
Antimicrobial Surgical Suture Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Antimicrobial Surgical Suture Market Share Outlook, CAGR 2031
Download Free Sample
Source: The Insight Partners Analysis
Based on application, the market is classified into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest antimicrobial surgical suture market share in 2023, and it is estimated to register the highest CAGR during 2023–2031. Cardiovascular surgeries require sutures that are made up of stainless steel and prolene, among others. These sutures are available with or without pledgets. Sutures are used with the needle made from the grades of alloy steel, which are much finer, stronger, and sharper than regular 420-grade steel. Coronary artery bypass grafting, heart valve repair or replacement, and arrhythmia treatment are among cardiovascular surgical procedures that require suturing. The market for cardiovascular surgery is likely to grow during the forecast period owing to factors such as the increasing incidence of cardiovascular disorders and hypertension, coupled with the rising geriatric population.
Smart Antimicrobial Sutures to Bring New Trends in Market in Coming Years
The RMIT Centre for Materials Innovation and Future Fashion is one of the organizations focusing on developing new, smart antimicrobial sutures to reduce the prevalence of surgical site infections. The center's suture products are made from materials that glow during medical imaging procedures; these stitches have the potential to replace mesh implants as promising alternatives. They can be beneficial in monitoring patient recovery progress, in addition to their impressive antimicrobial properties, preventing infections and killing 99% of highly drug-resistant bacteria after 6 hours of contact at body temperature. It may also significantly reduce surgery duration and increase surgical accuracy in general with the ability to visualize mesh location accurately on preoperative imaging. Thus, smart antimicrobial sutures are likely to bring new antimicrobial surgical suture market trends in the coming years.
Key players identified and evaluated while performing antimicrobial surgical suture market analysis are TI Medical, Healthium Medtech Limited, Meril Life Sciences Pvt Ltd, Unilene, Johnson & Johnson, Boz Medical, Futura Surgicare Pvt Ltd (Dolphin Sutures), Cencora, Inc. (AmerisourceBergen Corporation), Advanced MedTech Solutions Pvt. Ltd., and Internacional Farmacéutica SA.
The antimicrobial surgical suture market, by type, is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. Based on raw material, the market is categorized into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. In terms of application, the market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The geographic scope of the antimicrobial surgical suture market report encompasses North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the market in 2023. The antimicrobial surgical suture market size in North America is expected to register a CAGR of 9.6% during 2023–2031. Asia Pacific is expected to record the highest CAGR in the antimicrobial surgical suture market during the forecast period. The market in this region is expected to grow owing to factors such as the rising number of plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, an upsurge in research studies and healthcare expenditure is anticipated to fuel the antimicrobial surgical suture market growth during the forecast period.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com